February 17, 2022 Comments Off on New patent for Allergan Holdings drug VIBERZI Posted in: Patent Added Annual Drug Patent Expirations for VIBERZI Viberzi is a drug marketed by Allergan Holdings and is included in one NDA. It is available from one supplier. There are seventeen patents…
The post New patent for Allergan Holdings drug VIBERZI appeared first…
February 17, 2022 Comments Off on New patent for Alnylam Pharms drug GIVLAARI Posted in: Patent Added Annual Drug Patent Expirations for GIVLAARI Givlaari is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are twelve patents protecting this drug. This drug…
The post New patent for Alnylam Pharms drug GIVLAARI appeared first on D…
